Citadel Advisors’s Atossa Therapeutics ATOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-43,208
Closed -$382K 12959
2025
Q4
$382K Buy
43,208
+25,650
+146% +$324K ﹤0.01% 9628
2025
Q3
$228K Buy
17,558
+11,763
+203% +$145K ﹤0.01% 10964
2025
Q2
$72.1K Buy
+5,795
New +$69.3K ﹤0.01% 11565
2025
Q1
Sell
-28,521
Closed -$346K 14449
2024
Q4
$404K Buy
28,521
+17,728
+164% +$346K ﹤0.01% 9022
2024
Q3
$246K Sell
10,793
-2,640
-20% -$53.3K ﹤0.01% 9717
2024
Q2
$240K Buy
13,433
+5,029
+60% +$111K ﹤0.01% 9565
2024
Q1
$227K Buy
8,404
+7,795
+1,280% +$125K ﹤0.01% 10068
2023
Q4
$8.04K Sell
609
-2,401
-80% -$25.9K ﹤0.01% 13252
2023
Q3
$33.3K Buy
+3,010
New +$43.7K ﹤0.01% 12196
2023
Q1
Sell
-4,740
Closed -$52.9K 14686
2022
Q4
$37.6K Buy
4,740
+3,012
+174% +$34.6K ﹤0.01% 12488
2022
Q3
$21K Sell
1,728
-14,524
-89% -$211K ﹤0.01% 12053
2022
Q2
$266K Sell
16,252
-67,147
-81% -$1.06M ﹤0.01% 10083
2022
Q1
$1.56M Sell
83,399
-53,405
-39% -$1.08M ﹤0.01% 6633
2021
Q4
$3.28M Buy
136,804
+68,690
+101% +$2.51M ﹤0.01% 5159
2021
Q3
$3.33M Buy
+68,114
New +$3.96M ﹤0.01% 5135
2021
Q2
Sell
-2,271
Closed -$120K 13644
2021
Q1
$72K Sell
2,271
-645
-22% -$23.6K ﹤0.01% 12715
2020
Q4
$42K Buy
2,916
+1,281
+78% +$29.7K ﹤0.01% 10628
2020
Q3
$59K Buy
+1,635
New +$78.5K ﹤0.01% 9536
2019
Q3
Sell
-687
Closed -$21.8K 9142
2019
Q2
$26K Buy
+687
New +$27.5K ﹤0.01% 8899
2019
Q1
Sell
-2,295
Closed -$35K 9243
2018
Q4
$35K Buy
+2,295
New +$45.4K ﹤0.01% 8574
2018
Q2
Sell
-1,001
Closed -$80K 8801
2018
Q1
$80K Buy
+1,001
New +$93.2K ﹤0.01% 7786
2017
Q2
Sell
-64
Closed -$9K 7459
2017
Q1
$9K Buy
+64
New +$16.3K ﹤0.01% 7340
2016
Q1
Sell
-6
Closed -$5K 6749
2015
Q4
$5K Buy
+6
New +$9.23K ﹤0.01% 8446
2015
Q1
Sell
-5
Closed -$18K 8502
2014
Q4
$18K Hold
5
﹤0.01% 7885
2014
Q3
$20K Buy
+5
New +$24.6K ﹤0.01% 7409

Other funds holding ATOS